A randomized, phase 2 study of ASP0113, a DNA‐based vaccine, for the prevention of CMV in CMV‐seronegative kidney transplant recipients receiving a kidney from a CMV‐seropositive donor
Vincenti, Flavio, Budde, Klemens, Merville, Pierre, Shihab, Fuad, Ram Peddi, V., Shah, Malay, Wyburn, Kate, Cassuto‐Viguier, Elisabeth, Weidemann, Alexander, Lee, Misun, Flegel, Teresa, Erdman, Jay, Wang, Xuegong, Lademacher, Christopher
Published in American journal of transplantation (01.12.2018)
Published in American journal of transplantation (01.12.2018)
Get full text
Journal Article
Abstract CT132: Trial in progress: A phase 1/2 study of ASP1570, a novel inhibitor of DGKζ, in participants with locally advanced or metastatic solid tumors who have progressed on, or are ineligible for, all available standard therapies
Patel, Manish R., Park, David J., Tarantolo, Stefano, Dowlati, Afshin, Olson, Daniel, Kaneko, Yuichiro, Tang, Mei, Soukharev, Serguei, Takizawa, Masaomi, Okada, Yohei, Fredericks, Christine, Flegel, Teresa, Watanabe, Tsubasa, Lee, Sue, Luke, Jason John
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
754 A phase 1/2 study of ASP1570 in participants with locally advanced or metastatic solid tumors who have progressed on, or are ineligible for, all available standard therapies
Patel, Manish, Park, David, Tarantolo, Stefano, Dowlati, Afshin, Olson, Daniel, Kaneko, Yuichiro, Tang, Mei, Soukharev, Serguei, Takizawa, Masaomi, Okada, Yohei, Fredericks, Christine, Smith, Derek, Flegel, Teresa, Watanabe, Tsubasa, Lee, Sue, Luke, Jason
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article